Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review

March 2021 | 47 pages | ID: FF65A975FBEEN
GlobalData

Abstracts

Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Five Prime Therapeutics Inc (Five Prime) is a clinical state biopharmaceutical company focusing on the research and development of novel treatments for cancer and inflammatory disorders. The company’s developmental pipeline is based on the discovery platform and library of therapeutic proteins. The company’s pipeline products include cabiralizumab; Bemarituzumab (FPA144); FPT155; FPA157; and BMS-986258. Five Prime has also developed proprietary protein screening technologies and rapid in vivo protein production system to identify new targets for protein therapeutics. The company has development collaborations with various companies to advance its pipeline products. Five Prime is headquartered in South San Francisco, California, the US.

Five Prime Therapeutics Inc Key Recent Developments

Mar 09,2021: Five Prime Cancels Fourth Quarter and Full-Year 2020 Financial Results Conference Call
Mar 05,2021: Amgen signs agreement to acquire Five Prime Therapeutics for $1.9bn
Mar 02,2021: Five Prime Therapeutics Announces Timing of Its Fourth Quarter 2020 and Full Year Results Conference Call
Nov 03,2020: Five Prime Therapeutics reports third quarter 2020 results
Aug 06,2020: Five Prime Therapeutics reports second quarter 2020 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Five Prime Therapeutics Inc - Key Facts
Five Prime Therapeutics Inc - Key Employees
Five Prime Therapeutics Inc - Key Employee Biographies
Five Prime Therapeutics Inc - Major Products and Services
Five Prime Therapeutics Inc - History
Five Prime Therapeutics Inc - Company Statement
Five Prime Therapeutics Inc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Company Overview
Five Prime Therapeutics Inc - Business Description
Five Prime Therapeutics Inc - Corporate Strategy
Five Prime Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Five Prime Therapeutics Inc - Strengths
Five Prime Therapeutics Inc - Weaknesses
Five Prime Therapeutics Inc - Opportunities
Five Prime Therapeutics Inc - Threats
Five Prime Therapeutics Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Five Prime Therapeutics Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 09, 2021: Five Prime Cancels Fourth Quarter and Full-Year 2020 Financial Results Conference Call
Mar 02, 2021: Five Prime Therapeutics Announces Timing of Its Fourth Quarter 2020 and Full Year Results Conference Call
Nov 03, 2020: Five Prime Therapeutics reports third quarter 2020 results
Aug 06, 2020: Five Prime Therapeutics reports second quarter 2020 results
May 07, 2020: Five Prime Therapeutics reports first quarter 2020 results
Apr 14, 2020: Five Prime Therapeutics appoints Tom Civik as chief executive officer
Feb 27, 2020: Five Prime Therapeutics reports fourth quarter and full year 2019 results
Feb 20, 2020: Seattle Genetics in-licenses some of Five Prime’s antibodies for $5m
Feb 13, 2020: Five Prime Therapeutics Announces Timing of Its Fourth Quarter and Full Year 2019 Results Conference Call

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Five Prime Therapeutics Inc, Key Facts
Five Prime Therapeutics Inc, Key Employees
Five Prime Therapeutics Inc, Key Employee Biographies
Five Prime Therapeutics Inc, Major Products and Services
Five Prime Therapeutics Inc, History
Five Prime Therapeutics Inc, Key Competitors
Five Prime Therapeutics Inc, Annual Ratios
Five Prime Therapeutics Inc, Annual Ratios (Cont...1)
Five Prime Therapeutics Inc, Interim Ratios
Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Five Prime Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Five Prime Therapeutics Inc, Performance Chart (2016 - 2020)
Five Prime Therapeutics Inc, Ratio Charts
Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Five Prime Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021